The inflammatory spectrum of gastric diseases includes different clinico-pathological
entities, the etiology of which was recently established in the international Kyoto …

Immune checkpoint inhibitors (ICIs) are the standard of care for the treatment of several
cancers. While these immunotherapies have improved patient outcomes in many clinical …

Immunotherapy has transformed the treatment landscape of many cancers, with durable
responses in disease previously associated with a poor prognosis. Patient selection remains …

Gastric biopsies represent one of the most frequent specimens that the pathologist faces in
routine activity. In the last decade or so, the landscape of gastric pathology has been …

At the end of the last century, a far-sighted 'working party'held in Sydney, Australia
addressed the clinicopathological issues related to gastric inflammatory diseases. A few …

Context.—Immune checkpoint inhibitors (CPIs), including cytotoxic T-lymphocyte–
associated protein 4 (CTLA-4) inhibitors and the programmed death receptor-1 (PD …

Aims A varied spectrum of histopathological changes has been associated with immune
checkpoint inhibitor (ICI) colitis. This study was performed to evaluate the prevalence of …

Background and study aims Recent advances in cancer treatment have involved the clinical
application of immune checkpoint inhibitors (ICIs) for various type of cancers. The adverse …

Immune checkpoint blockade using PD-1 inhibition is an effective approach for treating a
wide variety of cancer subtypes. While lower gastrointestinal (GI) side effects are more …

Drugs are widely used to treat different diseases in modern medicine, but they are often
associated with adverse events. Those located in the gastrointestinal tract are common and …